DK585889D0 - Farmaceutisk praeparat - Google Patents

Farmaceutisk praeparat

Info

Publication number
DK585889D0
DK585889D0 DK585889A DK585889A DK585889D0 DK 585889 D0 DK585889 D0 DK 585889D0 DK 585889 A DK585889 A DK 585889A DK 585889 A DK585889 A DK 585889A DK 585889 D0 DK585889 D0 DK 585889D0
Authority
DK
Denmark
Prior art keywords
polyoxyethylene glycol
component
carboxylic acid
pharmaceutical preparation
ester
Prior art date
Application number
DK585889A
Other languages
English (en)
Other versions
DK585889A (da
Inventor
Maria Oksana Bachynsky
Martin Howard Infeld
Navnit Shah
Joel Unowsky
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK585889D0 publication Critical patent/DK585889D0/da
Publication of DK585889A publication Critical patent/DK585889A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/25—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids with polyoxyalkylated alcohols, e.g. esters of polyethylene glycol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
DK585889A 1988-11-22 1989-11-21 Farmaceutisk praeparat DK585889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27459088A 1988-11-22 1988-11-22

Publications (2)

Publication Number Publication Date
DK585889D0 true DK585889D0 (da) 1989-11-21
DK585889A DK585889A (da) 1990-05-23

Family

ID=23048828

Family Applications (1)

Application Number Title Priority Date Filing Date
DK585889A DK585889A (da) 1988-11-22 1989-11-21 Farmaceutisk praeparat

Country Status (15)

Country Link
EP (1) EP0370481B1 (da)
JP (1) JPH0774165B2 (da)
KR (1) KR900007412A (da)
AT (1) ATE94765T1 (da)
AU (1) AU625276B2 (da)
CA (1) CA2003340A1 (da)
DE (1) DE58905681D1 (da)
DK (1) DK585889A (da)
HU (1) HU205713B (da)
IE (1) IE63119B1 (da)
IL (1) IL92357A (da)
NZ (1) NZ231447A (da)
PH (1) PH26390A (da)
YU (1) YU221889A (da)
ZA (1) ZA898331B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115849A1 (de) * 1991-05-15 1992-11-19 Lohmann Therapie Syst Lts Penetrationsfoerdernde substanz
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
SI9400338A (en) * 1994-08-31 1996-04-30 Lek D D Vancomycin hydrochloride suspensions for peroral use and for filling into soft ,gelatine capsules.
IT1275802B1 (it) * 1994-11-03 1997-10-17 Hoffmann La Roche Composizione di interferone
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
IL125244A (en) * 1998-07-07 2002-12-01 Yissum Res Dev Co Pharmaceutical compositions containing low-melting waxes
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
ES2301477T3 (es) * 1999-02-22 2008-07-01 Merrion Research I Limited Forma de dosificacion oral solida que contiene un potenciador.
WO2002092616A1 (en) 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
EP2007397B1 (en) 2006-04-07 2013-07-24 Merrion Research III Limited Solid oral dosage form containing an enhancer
US8999383B2 (en) 2008-05-07 2015-04-07 Merrion Research Iii Limited Compositions of GnRH related compounds and processes of preparation
BRPI0918652B1 (pt) 2008-09-17 2021-10-19 Chiasma, Inc. Composição farmacêutica compreendendo um meio hidrofóbico e uma forma sólida que compreende polipeptídeo e sal de ácido graxo de cadeia média, processo de produção da mesma e forma de dosagem oral
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
MA41462A (fr) 2015-02-03 2021-05-12 Chiasma Inc Méthode de traitement de maladies
US11141457B1 (en) 2020-12-28 2021-10-12 Amryt Endo, Inc. Oral octreotide therapy and contraceptive methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1168949A (en) * 1979-08-13 1984-06-12 William G. Gorman Cleansing compositions
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS59212427A (ja) * 1983-05-19 1984-12-01 Kyoto Yakuhin Kogyo Kk 直腸投与用組成物
EP0126348A2 (en) * 1983-05-19 1984-11-28 Kyoto Pharmaceutical Industries, Ltd. Composition for rectal administration and method of promoting rectal drug absorption
CA1256799A (en) * 1984-02-22 1989-07-04 Walter Fuller Suppositories
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
IL92357A (en) 1994-10-07
NZ231447A (en) 1992-09-25
IL92357A0 (en) 1990-07-26
EP0370481A3 (de) 1991-01-16
AU625276B2 (en) 1992-07-09
KR900007412A (ko) 1990-06-01
DE58905681D1 (de) 1993-10-28
AU4538489A (en) 1990-05-31
JPH02180837A (ja) 1990-07-13
ZA898331B (en) 1990-07-25
HUT52374A (en) 1990-07-28
EP0370481B1 (de) 1993-09-22
IE893718L (en) 1990-05-22
PH26390A (en) 1992-07-02
JPH0774165B2 (ja) 1995-08-09
IE63119B1 (en) 1995-03-22
YU221889A (en) 1992-05-28
DK585889A (da) 1990-05-23
CA2003340A1 (en) 1990-05-22
ATE94765T1 (de) 1993-10-15
EP0370481A2 (de) 1990-05-30
HU205713B (en) 1992-06-29
HU896123D0 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
DK585889A (da) Farmaceutisk praeparat
DE3669882D1 (de) 2-zyanakrylsaeureester enthaltende zusammensetzung.
NO863061D0 (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
DK581185D0 (da) Farmaceutisk praeparat indeholdende 13-cis-a-vitaminsyre
DE3586545T2 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
DE3884517T2 (de) Biologisch aktive Carbonsäureester.
MY100647A (en) Pharmaceuticals formulations.
DE3778132D1 (de) 2-beta-substituierte methylpenicillansaeure-derivate und deren salze und ester.
DE3674351D1 (de) Optisch aktive benzoesaeureesterderivate.
IL65922A0 (en) Preparation of apovincaminic acid esters,certain novel optically active derivatives thereof and pharmaceutical compositions containing them
IT8267345A0 (it) Composto e composizione farmaceutica per accelerare la cicatrizzazione di ferite
PH21875A (en) Novel carboxylic acid esters,their method of use and insecticides containing them as the active ingredient
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DE3768557D1 (de) Trans-hexahydroterephthalsaeureesterderivate.
IT8619288A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
DE68918924T2 (de) Phosphorsäureester.
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
NL8100209A (nl) Methylpenamcarbonzuursulfonen, zouten en esters daarvan, alsmede geneeskundige preparaten, die deze verbindingen als actieve component bevatten.
IT8447848A0 (it) Acidi 7-(1-pirril)- e 7-(1-pirrolidinil)-6-fluoro-1-etil-1,4-diidro4-chetochinolin-3-carbossilici adattivita' antimicrobiche, loro procedimento di preparazione e composti farmaceutici che li contengono
DE191912T1 (de) 2-adamantanonoxim-karbaminsaeureesterderivate.
JPS56128731A (en) Ester of arylpropionic acid, manufacture and medicine of effective ingredient
ATE95164T1 (de) Biologisch aktive carbonsaeureester.
NO851195L (no) Fremgangsmaate for fremstilling av askorbinsyreestere.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment